Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    28-September-2000      
Issue 168 Next Update - 14:00 UTC 08:00 EST    29-September-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Proceed To Article In Today's Vidyya
Man & scale
A new chemotherapeutic regimen extends the survival rate for colorectal cancer patients.

Proceed To Article Screening For Colorectal Cancer - Information For Health Professionals
Screening for colorectal cancer is recommended for all persons aged 50 and older with annual fecal occult blood testing (FOBT), or sigmoidoscopy or both. More...

Proceed To Article Revised Breast Cancer Treatment Guidelines For Patients Now Available
Breast cancer patients now have a more comprehensive resource in their fight against cancer, thanks to the commitment of the National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS). Version III of the NCCN Breast Cancer Treatment Guidelines for Patients is now available. Originally launched in March 1999, this well-received resource for breast cancer patients has been updated to reflect changes to the current NCCN Breast Cancer Guidelines. More...

Proceed To Article New Colorectal Chemotherapy Regimen Improves Patient Survival Rates
A new chemotherapy regimen prolongs survival rates for patients with metastatic (advanced) colorectal cancer, according to an international study published today in The New England Journal of Medicine. More...

Proceed To Article Prescribing Information - Camptosar
Camptosar (irinotecan hydrochloride) is a relatively new drug that exhibits antineoplastic properties against certain types of colorectal carcinoma. Get the complete prescribing information and read the instructions for the safe handling of chemotherapeutic agents in this package insert. More...

Proceed To Article

FDA Approves Arsenic Trioxide For Leukemia Treatment In Record Time
The FDA has approved Trisenox (arsenic trioxide) for the treatment of patients with acute promyelocytic leukemia (APL) who have not responded to, or have relapsed following the use of all trans-retinoic acid and anthracycline-based chemotherapy, which is considered first line therapy. More...

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.